tiprankstipranks
Trending News
More News >
UCB SA (DE:UNC)
XETRA:UNC

Compare UCB SA (UNC) vs. Competitors

Compare
38 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
UCB SA
€244.20
€46.85B
29.10
35.29%
6 Buy
2 Hold
0 Sell
Strong Buy
UCB SA
€245.92
€46.85B
29.10
37.10%
6 Buy
2 Hold
0 Sell
Strong Buy
AstraZeneca
13896.00 p
£215.50B
28.13
17.68%
13 Buy
2 Hold
1 Sell
Strong Buy
GlaxoSmithKline
1950.50 p
£78.03B
12.93
29.09%
3 Buy
6 Hold
3 Sell
Hold
Hikma Pharmaceuticals
1554.00 p
£2.73B
11.21
-37.98%
3 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:UNC
UCB SA
244.20
66.14
37.15%
GB:0NZT
UCB SA
245.92
67.83
38.08%
GB:AZN
AstraZeneca
13,896.00
2,486.84
21.80%
GB:GSK
GlaxoSmithKline
1,950.50
500.42
34.51%
GB:HIK
Hikma Pharmaceuticals
1,254.00
-680.72
-35.18%
GB:INDV
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts